Capecitabine and Oxaliplatin for Advanced Esophagogastric CancerDavid Cunningham, A. Norman, Naureen Starling et al.|New England Journal of Medicine|2008Cited by 2.3k
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoidsM. Caplin, Zeng Zheng-Pei, William D. Travis et al.|Annals of Oncology|2015Cited by 698
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trialGary Middleton, John P. Neoptolemos, Paul Silcocks et al.|The Lancet Oncology|2014Cited by 374
Thromboembolism in Patients With Advanced Gastroesophageal Cancer Treated With Anthracycline, Platinum, and Fluoropyrimidine Combination Chemotherapy: A Report From the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies GroupNaureen Starling, A. Norman, Sheela Rao et al.|Journal of Clinical Oncology|2009Cited by 167
Randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric (OG) cancer: The REAL 2 trialDavid Cunningham, A. R. Norman, Sujaya Rao et al.|Journal of Clinical Oncology|2006Cited by 108